A subject receives a shot in the first-stage safety study clinical trial of a potential vaccine by Moderna for COVID-19 at the Kaiser Permanente Washington Health Research Institute in Seattle, March 16, 2020. THE CANADIAN PRESS/AP-Ted S. Warren